With 91916.0 shares changed hands, the volume of the stock remained heavier than its average volume of 83800.0 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $9.188 whereas the lowest price it dropped to was $8.45. The 52-week range on NTHI shows that it touched its highest point at $25.00 and its lowest point at $3.20 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NTHI was up-trending over the past week, with a rise of 27.41%, but this was down by -2.67% over a month. Three-month performance surged to 22.85% while six-month performance rose 16.19%.
Float and Shares Shorts:
At present, 19.47 million NTHI shares are outstanding with a float of 3.08 million shares on hand for trading. On 2025-11-14, short shares totaled 94246.0, which was 47.999998000000005 higher than short shares on 1760486400. In addition to Dr. Thomas C. Chen M.D., Ph.D. as the firm’s Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman, Mr. Keithly A. Garnett serves as its Chief Financial Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, NTHI reported revenue of $0.0 and operating income of -$6934647.0. The EBITDA in the recently reported quarter was -$7347635.0 and diluted EPS was -$0.45.
